GSA Capital Partners LLP Takes $312,000 Position in Orthofix Medical Inc. (NASDAQ:OFIX)

GSA Capital Partners LLP purchased a new stake in shares of Orthofix Medical Inc. (NASDAQ:OFIX) in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund purchased 19,977 shares of the medical device company’s stock, valued at approximately $312,000.

Other large investors also recently bought and sold shares of the company. nVerses Capital LLC bought a new position in Orthofix Medical in the second quarter worth approximately $27,000. Quest Partners LLC bought a new position in Orthofix Medical in the second quarter worth approximately $64,000. Zurcher Kantonalbank Zurich Cantonalbank raised its stake in Orthofix Medical by 25.5% in the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 9,435 shares of the medical device company’s stock worth $125,000 after buying an additional 1,919 shares in the last quarter. Arizona State Retirement System bought a new position in Orthofix Medical in the second quarter worth approximately $139,000. Finally, XTX Topco Ltd bought a new position in Orthofix Medical in the second quarter worth approximately $175,000. Institutional investors own 89.76% of the company’s stock.

Analysts Set New Price Targets

A number of brokerages recently commented on OFIX. Roth Mkm reissued a “buy” rating and issued a $22.00 price objective (up previously from $20.00) on shares of Orthofix Medical in a research note on Friday, November 8th. Stifel Nicolaus raised shares of Orthofix Medical from a “hold” rating to a “buy” rating and lifted their price target for the stock from $18.00 to $24.00 in a report on Friday, November 8th. Two investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $23.00.

Orthofix Medical Trading Up 1.2 %

Shares of Orthofix Medical stock opened at $18.91 on Friday. The firm has a 50-day simple moving average of $16.58 and a two-hundred day simple moving average of $15.61. The company has a market cap of $722.55 million, a P/E ratio of -6.04 and a beta of 1.05. Orthofix Medical Inc. has a fifty-two week low of $10.28 and a fifty-two week high of $20.73. The company has a debt-to-equity ratio of 0.25, a quick ratio of 1.11 and a current ratio of 2.39.

Orthofix Medical Profile

Orthofix Medical Inc operates as a spine and orthopedics company in the United States, Italy, Germany, the United Kingdom, France, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures and distributes bone growth stimulator devices for enhance of bone fusion, including adjunctive and noninvasive treatment of cervical and lumbar spine, as well as a therapeutic treatment for non-spine; designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and offers biological products, such as fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, and synthetic bone void fillers, and tissue forms, which allow physicians to treat various spinal and orthopedic conditions.